References
1. Goldacre M. The role of cohort studies in medical research. Pharmacoepidemiol Drug Saf. 2001; 10:5–11.
2. Singh G. Arthritis, rheumatism and aging medical information system postmarketing surveillance program. J Rheumatol. 2001; 28:1174–9.
3. Matsuda Y, Singh G, Yamanaka H, Tanaka E, Urano W, Taniguchi A, et al. Validation of a Japanese version of the stanford health assessment questionnaire in 3,763 patients with rheumatoid arthritis. Arthritis Rheum. 2003; 49:784–8.
4. Yamanaka H, Tohma S. Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice. Mod Rheumatol. 2006; 16:75–6.
5. Yamanaka H, Inoue E, Singh G, Tanaka E, Nakajima A, Taniguchi A, et al. Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan. Mod Rheumatol. 2007; 17:283–9.
6. Bengtsson C, Nordmark B, Klareskog L, Lundberg I, Alfredsson L. Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis. 2005; 64:1588–94.
7. Kim YJ, Choi CB, Sung YK, Lee HS, Bae SC. Characteristics of Korean patients with RA: a single center study. J Korean Rheum Assoc. 2009; 16:204–12.
8. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001; 323:334–6.
9. Furst DE. Observational cohort studies and well controlled clinical trials–we need them both! J Rheumatol. 2004; 31:1476–7.